Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-dose versus multi-dose methotrexate for ectopic pregnancy
IRCT20120716010297N7Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Jul 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of methotrexate in Ectopic pregnancy (EP) (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Serum beta-hCG levels and Treatment outcome. Started Jul 2017; status: completed.
02
Drugs
methotrexate
03
Conditions
Ectopic pregnancy (EP)
Beyond the preview
Go deeper on IRCT20120716010297N7.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120716010297N7.